TSE:MFC

Manulife Financial (MFC.TO)

60.69
+0.02 (0.03%)
as of Jul 23, 2026, 8:00:00 pm Market Open.
1632 watching
0
Investor Insights
star iconJul 23, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed perspectives from various analysts, reflecting both its potential and current market position. While many experts acknowledge MFC's solid dividend yield and growth prospects, particularly in Asia, concerns about valuation and market conditions persist. The stock appears to be trading around 2x book value and has shown slow but steady growth, attracting attention from those looking for income rather than explosive growth. The consensus among experts is to proceed with caution and consider market pullbacks for optimal entry points, though some view the stock as a good long-term hold due to its stable dividend and cash flow. Overall, while there are positive signs, such as asset management improvements and capital growth, analysts advise careful monitoring given the mixed signals surrounding the broader financial sector's performance.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
DON'T BUY
A lot of people say the stock is a joke. But there is light at the end of the tunnel. When the stock market goes up, that is very positive for MFC. It is trading at less than book value and it could be worth $20 (book value) a year from now.
HOLD
Use it as a warrant on the market and will trade up and down with it because of its exposure to some of its long dated annuities. Looking for better markets into 2011 so would continue to Hold.
TOP PICK
4.079% bond due Aug 20/15. Raised a lot of capital and too big to fail. Come under a lot of pressure because of their MCCSR ratios and market has punished them. Very sensitive to interest-rate and equity market moves. If nothing happens economically, you get paid your coupon and get your money back.
SELL
You may want to take a tax loss and re-invest 30 days into the new year. Now is not a good time to buy it. They are having trouble building reserves against possible market decline. Wait for the stock to build a base before buying.
DON'T BUY
A horrible story for the past year. Undisclosed problems in their annuity business and now have problems in their US healthcare. Wait until you see the rise off of the flat line.
SELL
What a horrible trend. Some strength around the $10 level.
DON'T BUY
Hasn’t turned the corner yet because of its investment products where the risk is still quite high.
WAIT
Sept 30th quarter will give a good idea of where earnings are going. Expect they will report a loss but it will be embedded in the market. As long as there is not another nasty surprise, stock is probably bottoming around here. Above average risk purchase at this price. Wait for the loss to be reported before buying.
DON'T BUY
Have a great deal of earnings sensitivity to equities and credit markets. A 10% move on equity market has a 30% impact on their earnings. Doesn't like investing in situations like this.
DON'T BUY
Still nervous about this company. Whenever he thinks all the skeletons are out of the closet, there is one more. Most recent one tends to be long-term care insurance in the US.
COMMENT
A play on the stock market. If you think stock market is going to have a decent year in 2011 the stock will probably come back. Caller wants to write a $10 Put, which is selling a Put option. He takes on an obligation to buy the stock at $10. Keeps whatever premium he gets if stock closes above $10.
HOLD
Bonds callable February 16/11 and due 2016? Feels this will definitely be called in 2011.
TOP PICK
4.079% bond due August 20/15. Trades relatively cheap compared to the banks. Getting 3.75%-3.85% yield giving you about 1% more than a GIC or bank senior deposit note.
PAST TOP PICK
(A Top Pick Oct 2/09. Down 38%.) Was looking for it to recover along with the markets. Still owns but at a much reduced level.
PAST TOP PICK
(A Top Pick Sept 23/09. Down 40.67%.)
Showing 1,396 to 1,410 of 2,283 entries